Skip Navigation

European Heart Journal 1994 15(1):97-107;
Copyright © 1994 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by BAER, F. M.
Right arrow Articles by SECHTEM, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by BAER, F. M.
Right arrow Articles by SECHTEM, U.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1994 The European Society of Cardiology

Regional 99mTc-methoxyisobutyl-isonitrile-uptake at rest in patients with myocardial infarcts: comparison with morphological and functional parameters obtained from gradient-echo magnetic resonance imaging

F. M. BAER, K. SMOLARZ*, P. THEISSEN*, E. VOTH*, H. SCHICHA* and U. SECHTEM

Klinik III für Innere Medizin und Klinik und Poliklinik für Nuklearmedizin
*Klinik III für Innere Medizin und Klinik und Poliklinik für Nuklearmedizin der Universität zu Köln

Received 26 April 1993; revised 21 July 1993; .

Correspondence: Udo Sechtem, MD, Klinik III fudigrr Innere Medizin, Universität zu Köln, Joseph-Stelzmannstr. 9, D-50924 Köhn, Germany

Abstract

It is not yet clear whether 99mTc-methoxyisobutyl-isonitrile (MIBI)-uptake is a reliable indicator of myocardial viability, and a threshold value, differentiating viable from scarred myocardium, in comparison to a morphological and functional standard of reference has not been defined.

MIBI-uptake was quant in 800 segments from 55 patients with angiographically proven coronary artery disease with and without a history of myocardial infarction. Viable myocardium was defined from gradient-echo magnetic resonance images (MRI) as regions with systolic wall thickening or an end-diastolic wall thickness above the mean value – 2·5 SD of a healthy control group (n=21). Scar was defined as end-diastolic wall thickness >2·5 SD below the normal mean value and absent systolic wall thickening or wall thinning.

Mean MIBI-uptake of viable (n=676; 79 ± 14%) and scar segments by MRJ (n = 124, 31 ± 16%) was significantly different (P<0·001). Segmental MIBI-uptake vs end-diastolic wall thickness (r=0·7) and systolic wall thickening (r = 0·71) yielded a fair correlation. The highest values as regards sensitivity and specificity of MIBI-uptake in predicting the presence of scar were 89% and 96% respectively for MIBI-uptake ≤50%, However, of the 136 segments with MIBI-uptake ≤50%, 26 (19%) were viable by MRI, resulting in a positive predictive accuracy for scar tissue of 81%. Of the 26 segments diagnosed as scarred by MIBI-SPECT but viable by MRI, 25 (96%) were located in the inferoseptal region.

MIBI-SPECT seems useful in the detection of viable myocardium after anterior myocardial infarcts, but over-estimates scar in the inferoseptal regions. Perfusion defects in these regions could be confirmed or denied by additional evaluation of myocardial morphology and function by MRI or tissue metabolism by positron emission tomography (PET).

Key Words: Technetium-99m-hexakis-2-methoxyisobutyl-isonitrile (MIBI) • single photon emission computed tomography (SPECT) • gradient-echo magnetic resonance imaging (MRI) • viability • Q-wave myocardial infarction • non-Q-wave myocardial infarction


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
H.-M. J. Siebelink, P. K. Blanksma, H. J. G. M. Crijns, J. J. Bax, A. J. van Boven, T. Kingma, D. A. Piers, J. Pruim, P. L. Jager, W. Vaalburg, et al.
No difference in cardiac event-free survival between positron emission tomography-guided and single-photon emission computed tomography-guided patient management: A prospective, randomized comparison of patients with suspicion of jeopardized myocardium
J. Am. Coll. Cardiol., January 1, 2001; 37(1): 81 - 88.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
E. E. van der Wall, H. W. Vliegen, A. de Roos, and A. V.G. Bruschke
Magnetic Resonance Imaging in Coronary Artery Disease
Circulation, November 1, 1995; 92(9): 2723 - 2739.
[Abstract] [Full Text]


Home page
CirculationHome page
F. M. Baer, E. Voth, C. A. Schneider, P. Theissen, H. Schicha, and U. Sechtem
Comparison of Low-Dose Dobutamine–Gradient-Echo Magnetic Resonance Imaging and Positron Emission Tomography With [18F]Fluorodeoxyglucose in Patients With Chronic Coronary Artery Disease : A Functional and Morphological Approach to the Detection of Residual Myocardial Viability
Circulation, February 15, 1995; 91(4): 1006 - 1015.
[Abstract] [Full Text]


Home page
RadiologyHome page
J. N. Oshinski, H.-C. Han, D. N. Ku, and R. I. Pettigrew
Quantitative Prediction of Improvement in Cardiac Function after Revascularization with MR Imaging and Modeling: Initial Results
Radiology, November 1, 2001; 221(2): 515 - 522.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.